01 August 2005
Exhaled breath condensate as a method of sampling airway nitric oxide and othermarkers of inflammation.
Jia Liu, Paul ThomasMed Sci Monit 2005; 11(8): MT53-62 :: ID: 202430
Abstract
Most of the methods of investigating lung diseases have been invasive untilthe discovery that exhaled nitric oxide can be used as a surrogate marker of airway inflammation, particularlyin asthma. Exhaled nitric oxide (NO) is now established as a marker of airway inflammation. It has beenshown to correlate well with eosinophilic asthmatic airway inflammation, and to be able to predict declinein asthma control and airway function. Altered levels of NO are also associated with other inflammatorylung diseases. In addition, polymorphisms of the genes encoding the three nitric oxide synthases areassociated with phenotypic differences associated with lung diseases. Exhaled NO is, however, non-specific.It is therefore of importance that collecting exhaled breath condensate (EBC) has emerged as a potentialtool in the study of pulmonary diseases. The exhaled breath is collected in a cooling system which allowswater vapour to condense. The EBC contains a number of mediators relating to the NO pathway, includingnitrite as a metabolite of nitric oxide, nitrotyrosine, nitrosothiols plus small molecular mediatorsassociated with oxidative stress, including hydrogen ions, and hydrogen peroxide. In addition, reportsare emerging of the detection of larger molecules which not only include leukotrienes, prostaglandins,albumin and other proteins, such as cytokines, but also macromolecules, for example, DNA. EBC is becominga technique which will allow repeated non-invasive sampling from the respiratory tract thus assistingpulmonary research and possibly the monitoring of lung diseases.
Keywords: Biological Markers - analysis, Breath Tests - methods, Exhalation, Inflammation - metabolism, Nitric Oxide - analysis, Nitric Oxide - metabolism, Biological Markers - analysis, Breath Tests - methods, Exhalation, Inflammation - metabolism, Nitric Oxide - metabolism
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952